Gale RP - Search Results

1

Using real-world evidence in haematology.

Passamonti F, Corrao G, Castellani G, Mora B, Maggioni G, Della Porta MG, Gale RP. Passamonti F, et al. Among authors: gale rp. Best Pract Res Clin Haematol. 2024 Mar;37(1):101536. doi: 10.1016/j.beha.2024.101536. Epub 2024 Jan 27. Best Pract Res Clin Haematol. 2024. PMID: 38490764 Review.

2

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.

Barbui T, Passamonti F, Accorsi P, Pane F, Vannucchi AM, Velati C, Gale RP, Tura S, Barosi G. Barbui T, et al. Among authors: gale rp. Leukemia. 2018 Sep;32(9):2077-2081. doi: 10.1038/s41375-018-0199-5. Epub 2018 Jun 28. Leukemia. 2018. PMID: 29955128 No abstract available.

3

Pomalidomide is active in the treatment of anemia associated with myelofibrosis.

Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ, Thiele J, Kvasnicka HM, Vardiman JW, Zhang Y, Bekele BN, Mesa RA, Gale RP, Kantarjian HM. Tefferi A, et al. Among authors: gale rp. J Clin Oncol. 2009 Sep 20;27(27):4563-9. doi: 10.1200/JCO.2008.21.7356. Epub 2009 Aug 3. J Clin Oncol. 2009. PMID: 19652059 Free PMC article. Clinical Trial.

4

Methodological challenges in the development of endpoints for myelofibrosis clinical trials.

Barosi G, Tefferi A, Gangat N, Szuber N, Rambaldi A, Odenike O, Kröger N, Gagelmann N, Talpaz M, Kantarjian H, Gale RP. Barosi G, et al. Among authors: gale rp. Lancet Haematol. 2024 May;11(5):e383-e389. doi: 10.1016/S2352-3026(24)00067-X. Epub 2024 Apr 8. Lancet Haematol. 2024. PMID: 38604205 Review.

5

Prospects for achieving treatment-free remission in chronic myeloid leukaemia.

Saglio G, Gale RP. Saglio G, et al. Among authors: gale rp. Br J Haematol. 2020 Aug;190(3):318-327. doi: 10.1111/bjh.16506. Epub 2020 Feb 14. Br J Haematol. 2020. PMID: 32057102 Free PMC article. Review.

6

Johannes Joseph van Rood Pioneer in immuno-genetics (7 April 1926-21 July 2017).

Fibbe W, Gale RP. Fibbe W, et al. Among authors: gale rp. Leukemia. 2017 Nov;31(11):2286-2287. doi: 10.1038/leu.2017.278. Epub 2017 Oct 1. Leukemia. 2017. PMID: 28860656 No abstract available.

7

Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated?

Nakao S, Gale RP. Nakao S, et al. Among authors: gale rp. Leukemia. 2016 Nov;30(11):2127-2130. doi: 10.1038/leu.2016.206. Epub 2016 Sep 2. Leukemia. 2016. PMID: 27585953 No abstract available.

8

Response to Pfirrmann et al.'s comment on How should we interpret conclusions of TKI-stopping studies.

Chen J, Gale RP. Chen J, et al. Among authors: gale rp. Leukemia. 2024 Feb;38(2):463-464. doi: 10.1038/s41375-023-02128-z. Epub 2023 Dec 27. Leukemia. 2024. PMID: 38151660 Free PMC article. No abstract available.

9

Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it?

Barosi G, Zhang MJ, Gale RP. Barosi G, et al. Among authors: gale rp. Leukemia. 2014 Nov;28(11):2267-70. doi: 10.1038/leu.2014.220. Epub 2014 Jul 16. Leukemia. 2014. PMID: 25027516 No abstract available.

10

Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.

Barosi G, Massa M, Campanelli R, Fois G, Catarsi P, Viarengo G, Villani L, Poletto V, Bosoni T, Magrini U, Gale RP, Rosti V. Barosi G, et al. Among authors: gale rp. Leuk Res. 2017 Sep;60:18-23. doi: 10.1016/j.leukres.2017.06.004. Epub 2017 Jun 7. Leuk Res. 2017. PMID: 28622624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,144 results

Search Page